Core Viewpoint - The company plans to use RMB 5.75 million of its excess raised funds to permanently supplement its working capital, which accounts for 29.98% of the total excess funds raised [1][2][5]. Fundraising Overview - The company was approved to issue 33.34 million shares at a price of RMB 22.50 per share, raising a total of RMB 750.15 million. After deducting issuance costs of RMB 90.97 million, the net amount raised was RMB 659.18 million [2][6]. - The total amount of excess funds raised is RMB 19.18 million [5][6]. Use of Excess Funds - The company commits to using the excess funds solely for operations related to its main business and will not affect the funding needs of the investment projects. The company will not engage in high-risk investments or provide financial assistance to entities outside its controlling subsidiaries within 12 months after the use of these funds [1][7]. - The cumulative amount used for permanent working capital and bank loan repayment within any 12-month period will not exceed 30% of the total excess funds raised [5][7]. Approval Process - The proposal to use part of the excess funds was approved by the company's board of directors and supervisory board, and it is pending approval from the shareholders' meeting [8][9]. - The supervisory board believes that using part of the excess funds for working capital will enhance the efficiency of fund usage and reduce financial costs, aligning with the interests of the company and all shareholders [8].
澳华内镜: 关于使用部分超募资金永久补充流动资金的公告